Clinical Trials

96 studies in Hematology in Minnesota

  1. Consortium for the Sharing of Germ Line DNA and Tissue From Subjects With Mesothelioma
    1. Minnesota
  2. Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
    1. Minnesota
  3. A Phase II-R and a Phase III Trial Evaluating Both *Erlotinib (PH II-R) and Chemoradiation (PH III) as Adjuvant Treatment For Patients With Resected Head of Pancreas Adenocarcinoma
    1. Minnesota
  4. Biospecimen Resource for Familial Pancreas Research, a Data and Tissue Registry (Also Known as a Bio-repository, Bio-bank, Data and Tissue Database, Data and Tissue Bank, Etc.) to Help Advance Research in Familial Pancreas Disease
    1. Minnesota
  5. A Randomized Phase III Study of Bendamustine Plus Rituximab Versus Ibrutinib Plus Rituximab Versus Ibrutinib Alone in Untreated Older Patients (≥ 65 Years of Age) With Chronic Lymphocytic Leukemia (CLL)
    1. Minnesota
  6. A Multicenter, Double-blind, Placebo-controlled, Adaptive Phase 3 Trial of POL-103A Polyvalent Melanoma Vaccine in Post-resection Melanoma Patients With a High Risk of Recurrence
    1. Minnesota
  7. Treatment of Children With All Stages of Hepatoblastoma
    1. Minnesota
  8. Phase I Study of Z-Endoxifen as a Hormonal Therapy for Breast Cancer
    1. Arizona,
    2. Minnesota
  9. A Phase III Trial of Post-Surgical Stereotactic Radiosurgery (SRS) Compared With Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease
    1. Minnesota
  10. Phase IIIB, Open-label, Multi-Center Study of the Efficacy and Safety of Rigosertib Administered as 72-hour Continuous Intravenous Infusions in Patients With Myelodysplastic Syndrome With Excess Blasts Progressing On or After Azacitidine or Decitabine
    1. Minnesota
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. Next